Your browser doesn't support javascript.
loading
Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12-24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India.
Mangarule, S; Palkar, S; Mitra, M; Ravi, M D; Singh, R; Moureau, A; Jayanth, M V; Patel, D M; Ravinuthala, S; Patnaik, B N; Jordanov, E; Noriega, F.
Afiliación
  • Mangarule S; Sanofi Healthcare India Private Ltd (SHIPL), Hyderabad, India.
  • Palkar S; Bharati Vidyapeeth (Deemed to be) University Medical College, Pune, India.
  • Mitra M; Institute of Child Health, Kolkata, India.
  • Ravi MD; JSS Academy of Higher Education, JSS Medical College and Hospital, Mysore, India.
  • Singh R; Maulana Azad Medical College, New Delhi, India.
  • Moureau A; Sanofi Pasteur, Lyon, France.
  • Jayanth MV; Sanofi Healthcare India Private Ltd (SHIPL), Hyderabad, India.
  • Patel DM; Sanofi Pasteur, Swiftwater, PA, USA.
  • Ravinuthala S; Sanofi Healthcare India Private Ltd (SHIPL), Hyderabad, India.
  • Patnaik BN; Sanofi Healthcare India Private Ltd (SHIPL), Hyderabad, India.
  • Jordanov E; Sanofi Pasteur, Swiftwater, PA, USA.
  • Noriega F; Sanofi Pasteur, Swiftwater, PA, USA.
Vaccine X ; 11: 100190, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35899104

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Vaccine X Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Vaccine X Año: 2022 Tipo del documento: Article País de afiliación: India